Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$44.9K
3 trades · 3 insiders
Net · 90d
$-44.9K
Insiders on file
11
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Friedberg Ezra M | Director | 23 | $0 | $325.8K | 2026-10-02 |
| Pauls Matthew | Director | 13 | $0 | $53.5K | 2026-10-02 |
| Greenleaf Peter | Director | 8 | $0 | $54.4K | 2026-10-02 |
| Davis Todd C | Director, 10% Owner | 10 | $999.8K | $0 | 2026-06-11 |
| Francis Knuettel II | Chief Financial Officer | 10 | $0 | $40.3K | 2026-05-22 |
| Malamut Richard | Director | 7 | $0 | $12.3K | 2026-04-02 |
| Einhorn Andrew J. | Director | 1 | $0 | $0 | 2025-12-23 |
| LIGAND PHARMACEUTICALS INC | Director, 10% Owner | 6 | $0 | $0 | 2025-12-17 |
| Rangarao Sai | Chief Commercial Officer | 3 | $0 | $0 | 2025-07-02 |
| Baxter Richard B | Director | 3 | $0 | $0 | 2025-07-02 |
| Plesha Scott M. | CEO and President | 3 | $0 | $0 | 2025-07-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Pauls Matthew | Director | S Sale | 2026-10-02 | 2026-10-06 | 786 | $21.00 | $16.5K | 13,578 | SEC↗ |
| Greenleaf Peter | Director | S Sale | 2026-10-02 | 2026-10-06 | 797 | $21.17 | $16.9K | 23,087 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2026-10-02 | 2026-10-06 | 558 | $20.72 | $11.6K | 80,484 | SEC↗ |
| Greenleaf Peter | Director | S Sale | 2026-07-02 | 2026-07-07 | 85 | $27.27 | $2.3K | 23,884 | SEC↗ |
| Greenleaf Peter | Director | S Sale | 2026-07-02 | 2026-07-07 | 712 | $26.00 | $18.5K | 23,969 | SEC↗ |
| Pauls Matthew | Director | S Sale | 2026-07-02 | 2026-07-07 | 692 | $26.00 | $18.0K | 14,458 | SEC↗ |
| Pauls Matthew | Director | S Sale | 2026-07-02 | 2026-07-07 | 94 | $27.36 | $2.6K | 14,364 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2026-07-02 | 2026-07-07 | 24 | $27.33 | $656 | 81,042 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2026-07-02 | 2026-07-07 | 534 | $26.03 | $13.9K | 81,066 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2026-06-15 | 2026-06-17 | 59 | $27.94 | $1.6K | 81,600 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2026-06-15 | 2026-06-17 | 224 | $27.12 | $6.1K | 81,659 | SEC↗ |
| Davis Todd C | Director | P Buy | 2026-06-11 | 2026-06-15 | 35,445 | $27.80 | $985.4K | 75,331 | SEC↗ |
| Davis Todd C | Director | P Buy | 2026-06-11 | 2026-06-15 | 503 | $28.73 | $14.5K | 75,834 | SEC↗ |
| Francis Knuettel II | CFO, Treas & Secty | D To issuer deriv | 2026-05-22 | 2026-05-26 | 42,500 | — | $0 | 0 | SEC↗ |
| Francis Knuettel II | CFO, Treas & Secty | A Award deriv | 2026-05-22 | 2026-05-26 | 59,500 | — | $0 | 59,500 | SEC↗ |
| Francis Knuettel II | CFO, Treas & Secty | D To issuer | 2026-05-22 | 2026-05-26 | 13,947 | — | $0 | 19,525 | SEC↗ |
| Francis Knuettel II | CFO, Treas & Secty | S Sale | 2026-05-22 | 2026-05-26 | 1,500 | $26.84 | $40.3K | 11,316 | SEC↗ |
| Friedberg Ezra M | Director | F Tax w/h | 2026-05-14 | 2026-05-18 | 144 | $27.01 | $3.9K | 81,883 | SEC↗ |
| Greenleaf Peter | Director | S Sale | 2026-04-02 | 2026-04-06 | 377 | $21.36 | $8.1K | 24,681 | SEC↗ |
| Greenleaf Peter | Director | S Sale | 2026-04-02 | 2026-04-06 | 420 | $20.52 | $8.6K | 25,058 | SEC↗ |
| Pauls Matthew | Director | S Sale | 2026-04-02 | 2026-04-06 | 415 | $20.52 | $8.5K | 15,521 | SEC↗ |
| Pauls Matthew | Director | S Sale | 2026-04-02 | 2026-04-06 | 371 | $21.36 | $7.9K | 15,150 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2026-04-02 | 2026-04-06 | 265 | $21.36 | $5.7K | 82,027 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2026-04-02 | 2026-04-06 | 293 | $20.51 | $6.0K | 82,292 | SEC↗ |
| Malamut Richard | Director | S Sale | 2026-04-02 | 2026-04-06 | 280 | $21.36 | $6.0K | 27,422 | SEC↗ |
| Malamut Richard | Director | S Sale | 2026-04-02 | 2026-04-06 | 310 | $20.51 | $6.4K | 27,702 | SEC↗ |
| Einhorn Andrew J. | Director | A Award | 2025-12-23 | 2025-12-29 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LIGAND PHARMACEUTICALS INC | Director, 10% Owner | A Award deriv | 2025-12-17 | 2025-12-19 | 0 | — | $0 | 0 | SEC↗ |
| LIGAND PHARMACEUTICALS INC | Director, 10% Owner | D To issuer deriv | 2025-12-17 | 2025-12-19 | 0 | — | $0 | 0 | SEC↗ |
| Pauls Matthew | Director | G Gift | 2025-12-10 | 2025-12-12 | 9,542 | — | $0 | 1,074 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2025-11-25 | 2025-11-26 | 2,000 | $28.14 | $56.3K | 32,001 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2025-11-25 | 2025-11-26 | 1 | $28.50 | $29 | 32,000 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2025-11-25 | 2025-11-26 | 2,000 | $28.01 | $56.0K | 30,000 | SEC↗ |
| Friedberg Ezra M | Director | S Sale | 2025-11-25 | 2025-11-26 | 5,999 | $28.00 | $168.0K | 34,001 | SEC↗ |
| Malamut Richard | Director | A Award | 2025-11-13 | 2026-04-01 | 2,454 | — | $0 | 8,904 | SEC↗ |
| LIGAND PHARMACEUTICALS INC | Director, 10% Owner | A Award deriv | 2025-11-06 | 2025-11-10 | 0 | $9000000.00 | $0 | 0 | SEC↗ |
| Pauls Matthew | Director | M Exercise deriv | 2025-10-02 | 2025-12-12 | 2,123 | — | $0 | 14,862 | SEC↗ |
| Pauls Matthew | Director | M Exercise | 2025-10-02 | 2025-12-12 | 2,123 | — | $0 | 10,616 | SEC↗ |
| Francis Knuettel II | CFO, Treas & Secty | A Award | 2025-07-02 | 2026-04-01 | 33,472 | — | $0 | 33,472 | SEC↗ |
| Baxter Richard B | Director | A Award | 2025-07-02 | 2026-04-01 | 19,108 | — | $0 | 19,108 | SEC↗ |
| Rangarao Sai | Chief Commercial Officer | A Award | 2025-07-02 | 2026-04-01 | 30,518 | — | $0 | 30,518 | SEC↗ |
| Pauls Matthew | Director | A Award | 2025-07-02 | 2026-04-01 | 25,478 | — | $0 | 25,478 | SEC↗ |
| Greenleaf Peter | Director | A Award | 2025-07-02 | 2026-04-01 | 25,478 | — | $0 | 25,478 | SEC↗ |
| Plesha Scott M. | CEO and President | A Award | 2025-07-02 | 2026-04-01 | 83,678 | — | $0 | 83,678 | SEC↗ |
| Malamut Richard | Director | A Award | 2025-07-02 | 2026-04-01 | 19,108 | — | $0 | 28,012 | SEC↗ |
| Davis Todd C | Director | A Award | 2025-07-02 | 2026-04-01 | 19,108 | — | $0 | 39,886 | SEC↗ |
| Friedberg Ezra M | Director | A Award | 2025-07-02 | 2026-04-01 | 19,108 | — | $0 | 82,585 | SEC↗ |
| Pauls Matthew | Director | M Exercise deriv | 2025-07-02 | 2025-12-12 | 8,493 | — | $0 | 16,985 | SEC↗ |
| Pauls Matthew | Director | M Exercise | 2025-07-02 | 2025-12-12 | 8,493 | — | $0 | 8,493 | SEC↗ |
| Malamut Richard | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 19,108 | — | $0 | 28,012 | SEC↗ |
| Malamut Richard | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 58,230 | — | $0 | 58,230 | SEC↗ |
| Friedberg Ezra M | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 58,230 | — | $0 | 58,230 | SEC↗ |
| Friedberg Ezra M | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 19,108 | — | $0 | 28,012 | SEC↗ |
| Davis Todd C | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 58,230 | — | $0 | 58,230 | SEC↗ |
| Davis Todd C | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 19,108 | — | $0 | 36,969 | SEC↗ |
| Francis Knuettel II | CFO, Treas & Secty | A Award deriv | 2025-07-02 | 2025-07-07 | 102,000 | — | $0 | 145,074 | SEC↗ |
| Francis Knuettel II | CFO, Treas & Secty | A Award deriv | 2025-07-02 | 2025-07-07 | 33,472 | — | $0 | 33,472 | SEC↗ |
| Pauls Matthew | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 77,640 | — | $0 | 77,640 | SEC↗ |
| Pauls Matthew | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 25,478 | — | $0 | 25,478 | SEC↗ |
| Greenleaf Peter | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 25,478 | — | $0 | 25,478 | SEC↗ |
| Greenleaf Peter | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 77,640 | — | $0 | 77,640 | SEC↗ |
| Baxter Richard B | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 58,230 | — | $0 | 58,230 | SEC↗ |
| Baxter Richard B | Director | A Award deriv | 2025-07-02 | 2025-07-07 | 19,108 | — | $0 | 19,108 | SEC↗ |
| Rangarao Sai | Chief Commercial Officer | A Award deriv | 2025-07-02 | 2025-07-21 | 93,000 | — | $0 | 93,000 | SEC↗ |
| Rangarao Sai | Chief Commercial Officer | A Award deriv | 2025-07-02 | 2025-07-21 | 30,518 | — | $0 | 30,518 | SEC↗ |
| Plesha Scott M. | CEO and President | A Award deriv | 2025-07-02 | 2025-07-23 | 255,000 | — | $0 | 255,000 | SEC↗ |
| Plesha Scott M. | CEO and President | A Award deriv | 2025-07-02 | 2025-07-23 | 83,678 | — | $0 | 83,678 | SEC↗ |
| LIGAND PHARMACEUTICALS INC | 10% Owner | C Conversion deriv | 2025-07-01 | 2025-07-03 | 15,000 | — | $0 | 3,000 | SEC↗ |
| LIGAND PHARMACEUTICALS INC | 10% Owner | J Other deriv | 2025-07-01 | 2025-07-03 | 31,279 | — | $0 | 34,279 | SEC↗ |
| Davis Todd C | Director, 10% Owner | J Other deriv | 2025-07-01 | 2025-07-03 | 31,279 | — | $0 | 3,127,868 | SEC↗ |
| Davis Todd C | Director, 10% Owner | C Conversion deriv | 2025-07-01 | 2025-07-03 | 15,000 | — | $0 | 3,000 | SEC↗ |
| Francis Knuettel II | Chief Financial Officer | J Other deriv | 2025-07-01 | 2025-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Francis Knuettel II | Chief Financial Officer | C Conversion deriv | 2025-07-01 | 2025-07-03 | 10,000 | — | $0 | 0 | SEC↗ |
| Friedberg Ezra M | Director | C Conversion deriv | 2025-07-01 | 2025-07-03 | 40,000 | — | $0 | 0 | SEC↗ |
| Friedberg Ezra M | Director | C Conversion deriv | 2025-07-01 | 2025-07-03 | 40,000 | — | $0 | 0 | SEC↗ |
| Friedberg Ezra M | Director | P Buy deriv | 2025-07-01 | 2025-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Friedberg Ezra M | Director | P Buy deriv | 2025-07-01 | 2025-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LIGAND PHARMACEUTICALS INC | 10% Owner | C Conversion | 2025-07-01 | 2025-07-03 | 1,500,000 | $10.00 | $15.00M | 1,500,000 | SEC↗ |
| Davis Todd C | Director, 10% Owner | C Conversion | 2025-07-01 | 2025-07-03 | 1,500,000 | $10.00 | $15.00M | 1,500,000 | SEC↗ |
| Francis Knuettel II | Chief Financial Officer | C Conversion | 2025-07-01 | 2025-07-03 | 10,000 | $10.00 | $100.0K | 10,000 | SEC↗ |
| Friedberg Ezra M | Director | C Conversion | 2025-07-01 | 2025-07-03 | 40,000 | $10.00 | $400.0K | 40,000 | SEC↗ |
| Friedberg Ezra M | Director | C Conversion | 2025-07-01 | 2025-07-03 | 40,000 | $10.00 | $400.0K | 40,000 | SEC↗ |
| Davis Todd C | Director | A Award | 2024-11-13 | 2026-04-01 | 4,961 | — | $0 | 20,778 | SEC↗ |
| Friedberg Ezra M | Director | A Award | 2024-11-13 | 2026-04-01 | 2,454 | — | $0 | 63,477 | SEC↗ |
| Malamut Richard | Director | A Award | 2024-06-14 | 2026-04-01 | 6,450 | — | $0 | 6,450 | SEC↗ |
| Davis Todd C | Director | A Award | 2024-06-14 | 2026-04-01 | 12,900 | — | $0 | 15,817 | SEC↗ |
| Friedberg Ezra M | Director | A Award | 2024-06-14 | 2026-04-01 | 6,450 | — | $0 | 61,023 | SEC↗ |